Matheus Lisatchok

Matheus Lisatchok

Auto-generated profile, based on publicly available information

Matheus Lisatchok

Universidade Estadual de Campinas (Unicamp), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
FLFabio Lau
Fabio Lau
MLMatheus Lisatchok
Matheus Lisatchok
JTJonas Belchior Tamanini
Jonas Belchior Tamanini
FGFabio Portela Gazmenga
Fabio Portela Gazmenga
DTDaniel Naves Araújo Texeira
Daniel Naves Araújo Texeira
CCCarlos Takahiro Chone
Carlos Takahiro Chone
According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed between 2004 and 2014 and used PS matching to analyze possible prognostic factors for its outcomes with regression analyses. Cox multiple regression analysis to study survival after PS matching shows that type of treatment was associated with death with a hazard ratio of 1.753 (p0.05). In the surgical treatment group, overall survival was 79.9% at one year, 36.4% at five years, and 20.5% at ten years. Disease-free survival was 90.1%, 64.8%, and 56.0% at 1, 5, and 10-years, respectively. In the non-surgical treatment group, overall survival was 60.6% at one year, 21.8% at five years, and 12.7% at ten years. Disease-free survival was 90.8%, 67.2%, and 57.8% at 1, 5, and 10-years, respectively. Patients in the surgical treatment group had better outcomes related to survival. Recurrence is associated with the survival of OPSCC cancer. Recurrence-free survival is similar to both treatments. 2C.